These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 926839)
1. Metabolic studies of ethylenediamine derivatives: absorption, tissue distribution and elimination of IF-ROM-203-14C compound. Nowicka A; Szukalski B; Prussak T; Jahn W Mater Med Pol; 1977; 9(3):239-43. PubMed ID: 926839 [No Abstract] [Full Text] [Related]
2. Absorption, distribution in tissues and routes of excretion of preparation IF-ROM-196 administered to rats orally. Nowicka A; Prussak T; Szukalski B Mater Med Pol; 1975; 7(4):304-7. PubMed ID: 1214517 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats. Nowicka A; Prussak T; Szukalski B Pol J Pharmacol Pharm; 1975; 27(2):113-20. PubMed ID: 168561 [TBL] [Abstract][Full Text] [Related]
4. Biochemical, morphochemical and pharmacodynamic evaluation of accumulation of ethylenediamine derivatives (ROM-203, MK-142) in some rat tissues. Noyszewska-Skibińska I; Nowicka A; Ernest K; Nowicka J Mater Med Pol; 1977; 9(3):216-24. PubMed ID: 926836 [No Abstract] [Full Text] [Related]
5. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats. Danek A; Witek J Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691 [TBL] [Abstract][Full Text] [Related]
6. [Biotransformation and excretion of N,N'-bis(3-(2-ethoxyphenoxy)-2-hydroxypropyl)ethylenediamine dihydrochloride (Falirytmin) in rats]. Pfeifer S; Plonka GR; Dobbrodt I; Franke P; Steenbeck L Pharmazie; 1990 Oct; 45(10):751-5. PubMed ID: 2128542 [TBL] [Abstract][Full Text] [Related]
7. In vitro study of (2S, 2'S) N,N'-dimethyl-N, N'-bis [1(3', 4', 5'-trimethoxybenzoyloxy) butyl-2] ethylenediamine salts and their bioavailability. Krówczyński L; Kluczykowska B; Stozek T; Wajdowicz A; Bartkowicz S Pol J Pharmacol Pharm; 1980; 32(6):909-15. PubMed ID: 7243687 [TBL] [Abstract][Full Text] [Related]
8. [The metabolic fate of the effective components of radix puerariae. II. The absorption, distribution and elimination of 14C-daidzein (author's transl)]. Su C; Zhu X Yao Xue Xue Bao; 1979; 14(3):129-34. PubMed ID: 506716 [No Abstract] [Full Text] [Related]
9. Studies on absorption, distribution, metabolism and excretion of bunitrolol, a beta-adrenergic blocking agent, in rats and mice. Suzuki T; Rikihisa T Arzneimittelforschung; 1979; 29(11):1707-15. PubMed ID: 44473 [No Abstract] [Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
11. [Changes in blood and tissue levels of C-14 ROM-196, a new ethylenediamine derivative and its excretion routes]. Nowicka A; Prussak T; Szukalski B Acta Pol Pharm; 1977; 34(1):109-14. PubMed ID: 848312 [No Abstract] [Full Text] [Related]
12. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat]. Klemm W; Morgenroth U; Joram U; Rodionov AP Pharmazie; 1985 Dec; 40(12):864-7. PubMed ID: 3841605 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol. Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters. Ernest K Pol J Pharmacol Pharm; 1975; 27(4):381-98. PubMed ID: 1166019 [TBL] [Abstract][Full Text] [Related]
15. Dose dependent disposition of [14C]-ICI 89,406 in the male rat: is this due to a capacity limited excretory pathway for the drug into bile? [proceedings]. Barnfield DJ; Bourne GR; Lowery C; Moss SR Br J Pharmacol; 1979 Jul; 66(3):492P. PubMed ID: 43182 [No Abstract] [Full Text] [Related]
16. Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effect. Lindstrom TD; Murphy PJ; Smallwood JK; Wiest SA; Steinberg MI J Pharmacol Exp Ther; 1982 Jun; 221(3):584-9. PubMed ID: 7086672 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
18. The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans. Marten TR; Bourne GR; Miles GS; Shuker B; Rankine HD; Dutka VN Drug Metab Dispos; 1984; 12(5):652-60. PubMed ID: 6149919 [TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog. Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]